Decentralized Strategies for Reaching Rare Populations
Decentralized Strategies for Reaching Rare Populations Reaching Rare Disease Patients Through Decentralized Trial Strategies Why Decentralization Matters in Rare Disease Clinical Trials Rare disease clinical trials often face the dual challenge of low patient numbers and wide geographic dispersion. Traditional site-based models are typically unviable due to the logistical burden placed on patients and families,…
Read More “Decentralized Strategies for Reaching Rare Populations” »